Eli Lilly to spin off animal health unit, quarterly profit beats estimates

Eli Lilly and Co announced on Tuesday it would spin off its Elanco animal health business and posted better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog.